Yanan Wu , Hongyi Zhao , Bin Wang , Xi Chen , Bo Jin , Yixuan Zheng , Chen Ma , Li Sheng , Yu Lu , Haihong Huang , Dongfeng Zhang
{"title":"优化吡咯-2-羧酸酰胺制备具有较好理化性能和可用药性的强效抗结核药物。","authors":"Yanan Wu , Hongyi Zhao , Bin Wang , Xi Chen , Bo Jin , Yixuan Zheng , Chen Ma , Li Sheng , Yu Lu , Haihong Huang , Dongfeng Zhang","doi":"10.1016/j.bioorg.2025.109016","DOIUrl":null,"url":null,"abstract":"<div><div>MmpL3, a mycobacterial membrane protein, is essential for the transport of trehalose monomycolate, which is crucial for the formation of the <em>M. tuberculosis</em> outer membrane and the survival of the bacterium. Herein, we optimize our lead MmpL3 inhibitor bearing pyrrole-2-carboxamide scaffold to develop antituberculosis agents with improved physicochemical properties. Compound <strong>27b</strong>, an optimized analog of our lead MmpL3 inhibitor, exhibited enhanced antituberculosis activity along with reduced cytotoxicity, improved microsomal stability, and high Caco-2 permeability. Significantly, the water solubility and pharmacokinetic profile of compound <strong>27b</strong> was markedly improved compared to the lead compound <strong>2</strong>. This compound demonstrated potent efficacy in decreasing the intracellular <em>M. tuberculosis</em> load within mouse macrophages. The results of this study indicated that incorporating an oxygen-containing group in pyrrole-2-carboxamide scaffold can improve the compound's LogP value, thereby achieving a balance between lipophilicity and antituberculosis activity.</div></div>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"165 ","pages":"Article 109016"},"PeriodicalIF":4.7000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Optimization of pyrrole-2-carboxamide to develop a potent antituberculosis agent with improved physicochemical property and druggability\",\"authors\":\"Yanan Wu , Hongyi Zhao , Bin Wang , Xi Chen , Bo Jin , Yixuan Zheng , Chen Ma , Li Sheng , Yu Lu , Haihong Huang , Dongfeng Zhang\",\"doi\":\"10.1016/j.bioorg.2025.109016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>MmpL3, a mycobacterial membrane protein, is essential for the transport of trehalose monomycolate, which is crucial for the formation of the <em>M. tuberculosis</em> outer membrane and the survival of the bacterium. Herein, we optimize our lead MmpL3 inhibitor bearing pyrrole-2-carboxamide scaffold to develop antituberculosis agents with improved physicochemical properties. Compound <strong>27b</strong>, an optimized analog of our lead MmpL3 inhibitor, exhibited enhanced antituberculosis activity along with reduced cytotoxicity, improved microsomal stability, and high Caco-2 permeability. Significantly, the water solubility and pharmacokinetic profile of compound <strong>27b</strong> was markedly improved compared to the lead compound <strong>2</strong>. This compound demonstrated potent efficacy in decreasing the intracellular <em>M. tuberculosis</em> load within mouse macrophages. The results of this study indicated that incorporating an oxygen-containing group in pyrrole-2-carboxamide scaffold can improve the compound's LogP value, thereby achieving a balance between lipophilicity and antituberculosis activity.</div></div>\",\"PeriodicalId\":257,\"journal\":{\"name\":\"Bioorganic Chemistry\",\"volume\":\"165 \",\"pages\":\"Article 109016\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioorganic Chemistry\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S004520682500896X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S004520682500896X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Optimization of pyrrole-2-carboxamide to develop a potent antituberculosis agent with improved physicochemical property and druggability
MmpL3, a mycobacterial membrane protein, is essential for the transport of trehalose monomycolate, which is crucial for the formation of the M. tuberculosis outer membrane and the survival of the bacterium. Herein, we optimize our lead MmpL3 inhibitor bearing pyrrole-2-carboxamide scaffold to develop antituberculosis agents with improved physicochemical properties. Compound 27b, an optimized analog of our lead MmpL3 inhibitor, exhibited enhanced antituberculosis activity along with reduced cytotoxicity, improved microsomal stability, and high Caco-2 permeability. Significantly, the water solubility and pharmacokinetic profile of compound 27b was markedly improved compared to the lead compound 2. This compound demonstrated potent efficacy in decreasing the intracellular M. tuberculosis load within mouse macrophages. The results of this study indicated that incorporating an oxygen-containing group in pyrrole-2-carboxamide scaffold can improve the compound's LogP value, thereby achieving a balance between lipophilicity and antituberculosis activity.
期刊介绍:
Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.
For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.
The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.